Acasă › Tulburare depresivă majoră › Arkansas
Studii clinice pentru Tulburare depresivă majoră în Arkansas
15 studii pentru Tulburare depresivă majoră caută participanți în Arkansas.
Orașe în Arkansas
Text oficial al studiului (în engleză)
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- SanRo Clinical Research Group LLC WCG Clinical Network, Bryant
În curs de recrutareFaza 3
Vârste de la 18 la 74 · Toate sexele · Actualizat 1 oct. 2026 · NCT07573176Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- SanRo Clinical Research Group LLC WCG Clinical Network, Bryant
În curs de recrutareFaza 3
Vârste de la 18 la 74 · Toate sexele · Actualizat 25 sept. 2026 · NCT06559306Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Little Rock
În curs de recrutareFaza 3
Vârste de la 18 la 65 · Toate sexele · Actualizat 24 sept. 2026 · NCT06830044A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Bryant
În curs de recrutareFaza 4
Vârste de 18 ani și peste · Toate sexele · Actualizat 18 sept. 2026 · NCT07105111A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Pillar Clinical Research, Bentonville
- SanRo Clinical Research Group, Bryant
În curs de recrutareFaza 3
Vârste de la 18 la 74 · Toate sexele · Actualizat 8 sept. 2026 · NCT07076407A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Little Rock
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 2 sept. 2026 · NCT07610473A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Bentonville
- Draig Clinical Site, Little Rock
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 26 aug. 2026 · NCT07300969NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Bryant
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 11 aug. 2026 · NCT06911112A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Preferred Research Partners, Inc., Little Rock
În curs de recrutareFaza 3
Vârste de la 18 la 74 · Toate sexele · Actualizat 10 aug. 2026 · NCT07592689A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Woodland International Research Group, Little Rock
- Woodland Research Northwest, Rogers
În curs de recrutareFaza 3
Vârste de la 18 la 74 · Toate sexele · Actualizat 3 aug. 2026 · NCT06775379Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Bryant
- Neurocrine Clinical Site, Little Rock
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 24 iul. 2026 · NCT06966401A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Preferred Research Partners /ID# 279206, Little Rock
- Woodland International Research Group /ID# 277605, Little Rock
În curs de recrutareFaza 2
Vârste de la 18 la 65 · Toate sexele · Actualizat 15 iun. 2026 · NCT07276997A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Pillar Clinical Research, LLC, Little Rock
- Preferred Research Partners, Inc., Little Rock
- Woodland Research Northwest, Rogers
În curs de recrutareFaza 2
Vârste de la 18 la 65 · Toate sexele · Actualizat 11 mai 2026 · NCT06524830Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Little Rock
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 29 oct. 2025 · NCT06786624Study of ALTO-300 in MDD
- Site 193, Rogers
În curs de recrutareFaza 2
Vârste de la 18 la 70 · Toate sexele · Actualizat 24 iul. 2025 · NCT05922878Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.